Nano-X Imaging Ltd.

NASDAQ:NNOX

Medical - Devices

Healthcare
$0.73 -1.45%

-$0.03 today

Market cap
$50.94M
Beta
1.17
P/E (TTM)
-1.5
EPS (TTM)
-$1.12
52W Low $1.59High $5.69

Volume 0.52M

Average 1.46M

NNOX Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Nano-X Imaging Ltd.NASDAQ: NNOX

Stock-Based Compensation · Q4 FY2025 · quarter ended Dec 2025

Stock-based compensation declines year over year

Q4 FY2025 stock-based compensation of $814K fell 42.5% year over year, in line with the -42.3% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 25.9% from the prior quarter. Over 3 fiscal years it compounded at -39.2% a year.

Context

  • Stock-based compensation amounted to 32.2% of revenue in FY2025, down 32.2 pp from a year earlier.
  • Stock-based compensation increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -42.5% toward the trailing-twelve-month pace of -42.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
$814K-25.9% QoQ
Last fiscal yearDec 2025
$4.19M-42.3% YoY
LTMDec 2025
$4.19M-42.3% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-42.5%——
1 year-42.3%——
3-year CAGR-39.2%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
4.19M USD
Year-over-year change
-42.3%
4-year CAGR
-31.3%

Stock-Based Compensation vs competitors

How NNOX compares with its peers on the latest reported figures

  • NNOX's LTM Dec 2025 stock-based compensation of $4.19M is the 9th largest of the 11 companies compared; the peer median is $9.07M.
  • Its year-over-year change of -42.3% is the 8th highest of 11, against a peer median of +23.8%.
  • Stock-based compensation amounts to 32.2% of revenue for NNOX, versus a peer median of 10.2%.
NNOX Competitors Peer median
Stock-Based Compensation for NNOX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCATHealth Catalyst, Inc.LTM Mar 2026$19.47M -47.1%-27.9%6.4%
OMOutset Medical, Inc.LTM Mar 2026$16.09M -33.3%-16.9%13.7%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$9.98M +67.1%+191.7%22.2%
QTRXQuanterix CorporationLTM Mar 2026$9.79M +79.2%+10.3%6.8%
CATXPerspective Therapeutics, Inc.LTM Mar 2026$9.42M +38.0%+88.2%1524.4%
HSDTSolana CompanyLTM Mar 2026$8.72M +217.8%—90.9%
INGNInogen, Inc.LTM Mar 2026$7.82M +9.7%-13.3%2.2%
PROFProfound Medical Corp.LTM Mar 2026$5.55M +98.0%+9.0%29.4%
NNOXNano-X Imaging Ltd.LTM Dec 2025$4.19M -42.3%-39.2%32.2%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$2.38M -344.3%—5.4%
MXCTMaxCyte, Inc.LTM Mar 2026$706K -76.8%—2.2%
Peer median (excluding NNOX) $9.07M+23.8%+9.0%10.2%

Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(61.8M)(105.24M)(60.78M)(53.52M)(75.02M)
Depreciation & Amortization2.29M11.51M11.81M11.73M11.7M
Deferred Income Tax(116K)(3.73M)(377K)(377K)(1.98M)
Stock-Based Compensation18.81M18.62M6.84M7.26M4.19M
Change in Working Capital2.75M(16.95M)(7.48M)(1.13M)2.77M
Accounts Receivables(40K)74K(507K)(321K)107K
Inventory864K00(277K)(325K)
Accounts Payables1.72M469K(153K)(1.32M)288K
Other Working Capital202K(17.49M)(6.82M)787K2.7M
Other Non-Cash Items(2K)52.4M5.21M(572K)17.54M
Operating Cash Flow(38.07M)(43.39M)(44.78M)(36.6M)(40.79M)
Capital Expenditures(23.16M)(7.17M)(3.3M)(2.77M)(4.21M)
Acquisitions (Net)(2.86M)1.01M000
Purchases of Investments(90.3M)(9.46M)(373K)(58.52M)(15K)
Sales of Investments90.3M31.24M39.11M41.19M33.8M
Other Investing Activities(90.3M)(1.01M)(373K)46K(200K)
Investing Cash Flow(116.32M)14.61M35.43M(20.05M)29.37M
Debt Repayment3.8M0000
Common Stock Issued3.58M949K27.14M37.83M21.37M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities3.58M804K113K1.67M0
Financing Cash Flow7.38M804K27.25M39.5M21.37M
Effect of Forex Changes(10K)(268K)(60K)72K(101K)
Net Change in Cash(147.01M)(28.24M)17.85M(17.07M)9.85M
Free Cash Flow(61.23M)(50.56M)(48.08M)(39.37M)(45M)

Nano-X Imaging Ltd.

NASDAQ:NNOX

Intrinsic Alpha fair value

Locked

Current Price

$0.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.